View Item 

Show simple item record

Treatment adherence with antipsychotic medications in bipolar disorder

dc.contributor.authorSajatovic, Marthaen_US
dc.contributor.authorValenstein, Marciaen_US
dc.contributor.authorBlow, Frederic C.en_US
dc.contributor.authorGanoczy, Daraen_US
dc.contributor.authorIgnacio, Rosalinda V.en_US
dc.date.accessioned2010-06-01T20:57:29Z
dc.date.available2010-06-01T20:57:29Z
dc.date.issued2006-06en_US
dc.identifier.citationSajatovic, Martha; Valenstein, Marcia; Blow, Frederic C; Ganoczy, Dara; Ignacio, Rosalinda V (2006). "Treatment adherence with antipsychotic medications in bipolar disorder." Bipolar Disorders 8(3): 232-241. <http://hdl.handle.net/2027.42/74052>en_US
dc.identifier.issn1398-5647en_US
dc.identifier.issn1399-5618en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74052
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16696824&dopt=citationen_US
dc.format.extent117423 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2006 Blackwell Munksgaarden_US
dc.subject.otherAtypical Antipsychoticen_US
dc.subject.otherBipolar Disorderen_US
dc.subject.otherComplianceen_US
dc.subject.otherTreatment Adherenceen_US
dc.titleTreatment adherence with antipsychotic medications in bipolar disorderen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychologyen_US
dc.subject.hlbtoplevelSocial Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.en_US
dc.contributor.affiliationotherCase Western Reserve University School of Medicine, Cleveland, OHen_US
dc.contributor.affiliationotherHealth Services Research and Development Service and Serious Mental Illness Treatment Research and Evaluation Center (SMITREC), Veterans Affairs Ann Arbor Health Systemen_US
dc.identifier.pmid16696824en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74052/1/j.1399-5618.2006.00314.x.pdf
dc.identifier.doi10.1111/j.1399-5618.2006.00314.xen_US
dc.identifier.sourceBipolar Disordersen_US
dc.identifier.citedreferenceColom F, Vieta E. Treatment adherence in bipolar patients. Clinical Approaches Bipolar Disorders 2002; 1: 49 – 56.en_US
dc.identifier.citedreferenceSuppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48: 1082 – 1088.en_US
dc.identifier.citedreferenceScott J. Predicting medication non-adherence in severe affective disorders. Acta Neuropsychiatr 2000; 12: 128 – 130.en_US
dc.identifier.citedreferenceMuller-Oerlinghausen B, Muser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992; 25: 261 – 269.en_US
dc.identifier.citedreferenceFrank E, Prien RF, Kupfer DJ, Alberts L. Implications of noncompliance on research in affective disorders. Psychopharmacol Bull 1985; 21: 37 – 42.en_US
dc.identifier.citedreferenceGoodwin FK, Jamison KR eds. Manic-depressive Illness. New York: Oxford University Press, 1990.en_US
dc.identifier.citedreferenceJamison KR, Gerner RH, Goodwin FK. Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry 1979; 36 ( 8 Spec No ): 866 – 869.en_US
dc.identifier.citedreferenceMiklowitz DJ. Longitudinal outcome and medication noncompliance among manic patients with and without mood-incongruent psychotic features. J Nerv Ment Dis 1992; 180: 703 – 711.en_US
dc.identifier.citedreferenceColom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated to treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000; 61: 549 – 555.en_US
dc.identifier.citedreferenceMaarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry 1988; 21: 121 – 125.en_US
dc.identifier.citedreferenceComtois KA, Ries R, Armstrong HE. Case manager ratings of the clinical status of dually diagnosed outpatients. Hosp Community Psychiatry 1994; 45: 568 – 573.en_US
dc.identifier.citedreferenceWeiss RD, Greenfield SF, Najavits LM et al. Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry 1998; 59: 172 – 174.en_US
dc.identifier.citedreferenceShemesh E, Yehuda R, Milo O et al. Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med 2004: 66: 521 – 526.en_US
dc.identifier.citedreferenceSchumann C, Lenz G, Berghofer A, Muller-Oerlinghausen B. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res 1999; 89: 247 – 257.en_US
dc.identifier.citedreferencePerlick DA, Rosenheck RA, Kaczynski R, Kozma L. Medication non-adherence in bipolar disorder: a patient-centered review of research findings. Clin Approach Bipolar Disord 2004; 3: 56 – 64.en_US
dc.identifier.citedreferenceSajatovic M, Hrouda D, Davies M. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv 2004; 55: 264 – 269.en_US
dc.identifier.citedreferenceAmerican Psychiatric Association. Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision). Washington, DC: American Psychiatric Press, 2002.en_US
dc.identifier.citedreferenceNemeroff CB. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry 2000; 61 ( Suppl. 13 ): 19 – 25.en_US
dc.identifier.citedreferenceCalabrese JR, Shelton MD, Rapport DJ, Kimmel SE. Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry 2002; 63 ( Suppl. 3 ): 5 – 9.en_US
dc.identifier.citedreferenceKeck PE, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The Expert Consensus Guideline Series: Treatment of Bipolar Disorder 2004. Postgraduate Medicine Special Report 2004; December: 1 – 116.en_US
dc.identifier.citedreferenceGilmer TP, Dolder CR, Lacro JP et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004; 161: 692 – 699.en_US
dc.identifier.citedreferenceSvarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 2001; 52: 805 – 811.en_US
dc.identifier.citedreferenceValenstein M, Blow FC, Copeland LA et al. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull 2004; 30: 255 – 264.en_US
dc.identifier.citedreferenceValenstein M, Copeland LA, Blow FC et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002; 40: 630 – 639.en_US
dc.identifier.citedreferenceDiMatteo MR. Variations in patients adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200 – 209.en_US
dc.identifier.citedreferenceCramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218 – 1224.en_US
dc.identifier.citedreferenceLingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002; 105: 164 – 172.en_US
dc.identifier.citedreferenceMukherjee S, Rosen AM, Shukla S. Acceptance by patients of maintenance lithium treatment. Lithium 1993; 2: 63 – 69.en_US
dc.identifier.citedreferenceJamison KR. Medication compliance. In: Goodwin FK, Jamison KR, eds. Manic Depressive Illness. Oxford: Oxford University Press, 1990: 756 – 757.en_US
dc.identifier.citedreferenceLenzi A, Lazzerini F, Placidi GF, Cassano GB, Akiskal HS. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Pharmacopsychiatry 1989; 22: 34 – 37.en_US
dc.identifier.citedreferenceKeck PE Jr, McElroy SL, Strakowski SM, Bourne ML, West SA. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 1997; 33: 87 – 91.en_US
dc.identifier.citedreferenceConnelly CE, Davenport YB, Nurnberger JI Jr. Adherence to treatment regimen in a lithium carbonate clinic. Arch Gen Psychiatry 1982; 39: 585 – 588.en_US
dc.identifier.citedreferenceKucera-Bozarth K, Beck NC, Lyss L. Compliance with lithium regimens. J Psychosoc Nurs Ment Health Serv 1982; 20: 11 – 15.en_US
dc.identifier.citedreferenceDanion JM, Neunreuther C, Krieger-Finance F, Imbs JL, Singer L. Compliance with long-term lithium treatment in major affective disorders. Pharmacopsychiatry 1987; 20: 230 – 231.en_US
dc.identifier.citedreferenceSajatovic M, Davies M, Bauer MS, McBride L, Hays RW, Jenkins J. Attitudes regarding the collaborative practice model and treatment adherence among individuals with bipolar disorder. Compr Psychiatry 2005; 46: 272 – 7.en_US
dc.identifier.citedreferenceScott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 2002; 63: 384 – 390.en_US
dc.identifier.citedreferenceKeck PE Jr, McElroy SL, Strakowski SM et al. Factors associated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry 1996; 57: 292 – 297.en_US
dc.identifier.citedreferenceSajatovic M, Bauer M, Kilbourne A, Vertrees J, Williford W. Self-reported medication adherence among veterans with bipolar disorder. Psychiatr Serv 2006; 57: 56 – 62.en_US
dc.identifier.citedreferenceSajatovic M, Shelton MD, Elhaj O et al. Treatment Adherence in Patients with Rapid Cycling Bipolar Disorder: Results from a Clinical Trials Setting. American Psychiatric Association Annual meeting. Poster presentation, Atlanta, Georgia; 2005.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1399-5618.2006.00314.x.pdf
Size:
114.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.